Jiangxi Yintao Pharmaceutical

Jiangxi Yintao Pharmaceutical is a privately held Chinese pharmaceutical company established in 2001 and based in Fuzhou, Jiangxi Province. The firm specializes primarily in the development and manufacture of herbal medicines targeting urogenital diseases such as leukorrhea. Its lead product, Xingxiang Tuerfeng Capsule, has been approved for the treatment of leukorrhea. Another program ("Yanli Capsule") appears to be under clinical investigation but details are sparse. The company's operations include R&D and manufacturing—likely with GMP standards—and it collaborates with other local pharma firms such as Jiangxi Juwang Pharmaceutical Co., Ltd. There is no evidence that the company operates outside China or that it possesses proprietary platform technologies beyond its focus on traditional/herbal formulations.